Clinical Trial Update: A Study of GZR18 Injection in Chinese Obese/Overweight Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial updating the investigation of GZR18 injection in obese/overweight adults in China has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• GZR18

Snippet

Sponsor: Gan and Lee Pharmaceuticals, USA | Conditions: Obesity, Overweight | Phase 1, Phase 2 | Status: COMPLETED